Natera Launches Panorama Non-Invasive Prenatal Test

The medical device is designed for detection of various chromosome abnormalities, including Down syndrome.

Natera, a leading innovator in reproductive and prenatal genetic testing, today announced that the company's non-invasive prenatal screening test, Panorama, will launch on March 1 for the detection of trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome) and select sex chromosome abnormalities, such as monosomy X (Turner's syndrome).

No votes yet
Syndicate content